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ABSTRACT: Cyclic voltammetry of the non-heme diiron enzyme porcine purple acid phosphatase (uteroferrin,
Uf) has been reported for the first time. Totally reversible one-electron oxidation responses (FeIII-FeII f
FeIII-FeIII) are seen both in the absence and in the presence of weak competitive inhibitors phosphate and
arsenate, and dissociation constants of these oxoanion complexes formed with uteroferrin in its oxidized
state (Ufo) have been determined. The effect of pH on the redox potentials has been investigated in the
range 3 < pH < 6.5, enabling acid dissociation constants for Ufo and its phosphate and arsenate complexes
to be calculated.
The purple acid phosphatases (PAPs)1 (1, 2) comprise a
subfamily of non-heme dinuclear iron containing proteins
that also include the ribonucleotide reductases, methane
monooxygenases, and hemerythrins (3). Several types of
PAPs have been isolated and studied from various plant (4-
7) and animal (8, 9) sources, although they appear to be even
more widespread in nature (10). Unlike other non-heme
dinuclear iron proteins, PAPs do not appear to undergo redox
transformations as a part of their function. Instead, they
catalyze the hydrolysis of a range of phosphate esters under
acidic conditions. However, their exact physiological function
remains uncertain (11). Recent data point to a role for
mammalian PAPs in bone resorption and raise the possibility
that the enzyme may be a drug design target for the treatment
of osteoporosis (12, 13).
Crystal structures have been reported for PAPs isolated
from pig uterus, also known as uteroferrin or Uf (Figure 1)
(14), rat bone (15), and red kidney bean (16, 17). All PAPs
bear an active site comprising a ferric ion (site A) and a
divalent metal ion (site B). In mammalian enzymes, the
divalent metal ion is Fe (8, 9), whereas in plant PAPs it may
be Zn or Mn. (5) Metal site A (FeIII) is coordinated to
terminal tyrosine, histidine, and aspartate ligands. The
terminal amino acid ligands to the divalent ion comprise two
histidines and an asparagine. The two metal sites are
simultaneously bridged by an aspartate and a water-based
ligand. Oxoanions such as phosphate are known to bind to
the active site of PAPs (such as Uf; Figure 1) (14). EXAFS
studies on phosphate free reduced (FeIII-FeII) Uf (18) and
its FeIII-ZnII analogue (19, 20) have suggested that water-
based (aqua/hydroxo) ligands complete six-coordinate, dis-
torted octahedral coordination spheres at both metal sites.
However, direct evidence for the exact number of water-
based ligands present in this active form is lacking. Red
kidney bean (FeIII-ZnII) PAP is the only member of this
family to have been characterized crystallographically in its
oxoanion-free form (16, 17), but the resolution of these
structures was too low to locate any terminal or bridging
water-based ligands. Recent ENDOR spectroscopic studies
(21) have suggested that Uf in its phosphate-free reduced
form bears a single terminal aqua/hydroxo ligand coordinated
to the FeII ion, but the ferric site is five coordinate.
Uteroferrin is the most thoroughly studied PAP (8, 22-
28). In its reduced, catalytically active state (Ufr), the active
site comprises an antiferromagnetically coupled (29, 30)
mixed valent FeIII-FeII center. The asymmetric coordination
environment of the two Fe ions in Uf (Figure 1) is also
reflected in their distinct redox behavior. The ferric site is
redox inert, while the ferrous ion may be oxidized to yield
a catalytically inactive di-FeIII form (Ufo), which is also
antiferromagnetically coupled (22, 29). Ufr undergoes pH-
dependent product (phosphate) inhibition (Ki 0.8-25 mM,
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FIGURE 1: Active site of Uf in its phosphate-inhibited form (from
ref 14).
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pH 3-6) (23). The labile ferrous ion in Ufr has been replaced
by other divalent metal ions such as Mn, Co, Ni, Cu, and
Zn (20, 28, 31, 32), with retention of phosphatase activity.
The ferric ion has been replaced by analogues such as AlIII
and GaIII to generate catalytically active enzymes, whereas
the InIII analogue was inactive (33).
Despite the intimate coupling between oxidation state and
enzymatic activity in PAPs, the electrochemical properties
of PAPs have received very little attention. Wang et al.
reported (34) the redox potentials of Uf as a function of pH
and also in the presence of selected oxoanions using
microcoulometry. This technique, a hybrid form of voltam-
metry and potentiometry, relies on the use of redox mediators
to poise the solution potential and to relay electrons between
the working electrode and the protein active site. No direct
(unmediated) electrochemical studies of a PAP have been
reported.
Unmediated protein voltammetry is becoming an increas-
ingly popular technique for the electrochemical investigation
of redox active proteins (35). Typically, the protein is
immobilized within a thin film coated onto the working
electrode surface where heterogeneous electron transfer may
take place without diffusion control. Moreover, voltammetry
is a time-dependent experiment and enables the investigation
of chemical reactions (including their rates) coupled to
electron transfer. It is this technique that we have employed
in this work to investigate the direct electrochemistry of Uf.
In addition, we have examined the influences of the redox-
inactive inhibitors phosphate and arsenate on the electro-
chemistry of Uf.
EXPERIMENTAL PROCEDURES
Uteroferrin was prepared as previously described (36).
Electrochemical measurements were carried out with a BAS
100B/W electrochemical analyzer and a BAS C3 cell stand.
An edge plane pyrolytic graphite-working electrode, cleaned
as described previously (37), a Pt wire counter electrode,
and an Ag/AgCl reference electrode were employed for all
experiments. All potentials are cited versus the normal
hydrogen electrode (NHE) using a correction of +196 mV
for the potential of the reference electrode. The working
electrode protein film was prepared by first mixing 5 íL of
a 200 íM solution of protein with 5 íL of a 2 mM solution
of the surfactant dimethyldidodecylammonium bromide
(DDAB). The resulting solution was added to the inverted
working electrode and dried overnight in a refrigerator.
All electrochemical measurements were made at 25 °C in
400 íL of a mixed buffer solution comprising bis-tris propane
(20 mM) and 2-amino-2-methylpropan-1-ol (20 mM) titrated
with the appropriate amount of acetic acid or NaOH to give
a final pH within the range 3-7. The supporting electrolyte
was 10 mM NaCl. The solution was purged with argon prior
to inserting the working electrode, and a blanket of argon
was maintained during the experiment. For experiments in
the presence of inhibiting anions, enzyme electroactivity was
first established, and then the appropriate salt was added
directly to the electrochemical cell to give final concentra-
tions of 100 mM KH2PO4 or 50 mM NaH2AsO4. The
reported voltammograms were initiated in the anodic (oxi-
dizing) direction (i.e., starting with the protein poised in its
reduced form Ufr), although experiments initiated in the
cathodic direction gave identical results. Cyclic voltammetry
scan rates were varied in the range of 20-200 mV s-1, while
for square wave voltammetry the step potential was 2 mV,
the square wave amplitude was 8 mV, and the square wave
frequency was 5 Hz. Background subtraction of cyclic
voltammetry waves was done with the program UTILS (38).
RESULTS AND DISCUSSION
A number of enzyme electrode preparations were inves-
tigated comprising various combinations of nonredox active
promoters (kanamycin, polymixin, polylysine) and also other
electrode surfaces (basal plane pyrolytic graphite, gold
modified with 4-mercaptopyridine), but none were as effec-
tive as the DDAB surfactant film method employing an edge
plane pyrolytic graphite electrode. The electroactive protein
film gave stable electrochemical responses for a period of a
few hours at room temperature.
The cyclic voltammograms of Uf at pH 4.1 are shown in
Figure 2 as a function of scan rate. A totally reversible one-
electron couple is seen with the averaged peak potential of
344 mV versus NHE. The same voltammograms corrected
for background current (Figure 3) enabled a more accurate
determination of the scan rate dependence of the peak
currents (Figure 3, inset). The linear dependence on scan
rate is indicative of a surface confined electrochemical
reaction (i.e., electron transfer is not diffusion controlled).
On the basis of a single electron-transfer process, and the
averaged gradients of the cathodic (-9.7  10-9) and anodic
peak (8.9  10-9) current plots, we calculate an electroactive
surface coverage of 10 pmol of protein (39). This is about
1% of protein used in the electrode preparation. Some protein
inevitably will adsorb onto insulated parts of the electrode
casing, and also some may leach from the film into the buffer
and be inaccessible for electron transfer. It is also possible
that multilayers of protein form within the film, but only
the proteins nearest the electrode surface are accessible.
Overall, the amounts of Uf that were required for reproduc-
ible voltammetry are about an order of magnitude greater
than we have used in other studies of cytochrome P450s (40)
and molybdoenzymes (41) immobilized within surfactant
films.
FIGURE 2: Cyclic voltammograms of Uf at pH 4.1. Curves are in
order of increasing current magnitude at scan rates 20, 50, 100,
and 200 mV s-1.
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The peak potentials do not change within the scan rate
range of 20-200 mV s-1, which reflects facile electron
transfer. The peak width at half-height remains fairly constant
(100-120 mV) and is consistent with that expected for a
single electron-transfer reaction of an adsorbed species (91
mV at 25 °C) (39). Finally, the ratio of cathodic to anodic
peak currents is approximately unity in all cases (ratio of
gradients in the inset to Figure 3), so reversibility of the
couple is not compromised by any coupled chemical reac-
tions.
The pH dependence of the Ufo/Ufr redox potential was
investigated in the range 3 < pH < 7, where the enzyme is
known to be stable and active (13). Such experiments provide
information on coupled electron/proton-transfer reactions at
the active site. For example, a linear variation of -59 mV/
pH unit for a single electron transfer is indicative of a single
deprotonation accompanying oxidation (and protonation
accompanying reduction). The redox potentials were deter-
mined by square wave voltammetry, which agreed with the
averaged cyclic voltammetry peak potentials, and the data
appear in Figure 4. Total electrochemical reversibility was
maintained across the pH range studied. Above pH 5.5, the
Ufo/Ufr redox potentials determined here coincide, within
experimental uncertainty, with those reported by Wang et
al. (34), although there is divergence below pH 5, where
the potentials determined here approach a plateau whereas
those determined by microcoulometry continue to rise
linearly with decreasing pH.
The variation in redox potentials (E(H+)) with pH observed
here is consistent with an active site pKa of ca. 5.2 for Ufo
according to eq 1 (42) for a single electron-transfer reaction
coupled to proton transfer.
In this case, at acidic-neutral pH values, Ufr is in its
protonated form (i.e., Ka(Ufr) , [H+]); thus, Ka(Ufr) may
be neglected from second term of eq 1, and the first and
third terms are pH independent. On the basis of crystal-
lographic and spectroscopic data for PAPs, the site of
deprotonation on Uf upon oxidation is most likely the
terminal aqua ligand bonded to the redox active ferrous ion.
Similar cyclic voltammetry and square wave voltammetry
experiments were performed for the phosphate and arsenate
bound forms of Uf. Again, no change in the totally reversible
cyclic voltammetry was found upon addition of either anion.
These oxoanions are known (23) to be rather weak competi-
tive inhibitors of Ufr (Kd  1-25 mM), so a large excess of
each anion was employed to ensure saturation of both Ufr
and Ufo during electrochemistry.
The pH-dependent redox potentials of the phosphate and
arsenate complexes were fit to eq 1, and values of pKa(Ufo/
PO4) ) 4.4 and pKa(Ufo/AsO4) ) 3.8 were determined.
Displacement of the ferrous-bound terminal water-based
ligand removes the group thought to be deprotonated (pKa
5.2) upon oxidation of Ufr. By elimination, it appears that
the pKa values determined for Ufo/PO4 and Ufo/AsO4
correspond to ionizations of the protonated coordinated
anions themselves. The acid dissociation constants for
dihydrogenphosphate (pKa 7.2) and dihydrogenarsenate (pKa
7.0) are upper bounds for the corresponding values of the
coordinated anions since inductive effects of the metal ions
must raise their acidities. Therefore, we propose that the
observed Ufo/XO4 pKa values correspond to deprotonation
of the coordinated H2XO4- anions upon oxidation of Ufr/
PO4. It is not known whether phosphate binds to Ufr in a
monodentate or bridging bidentate mode. EPR and kinetic
studies by Merkx et al. suggest (43) that phosphate acts as
a bridging ligand in Ufr/PO4 below pH 6.5 (the range we
have investigated) but that monodentate coordination occurs
at higher pH. A bridging bidentate coordination mode in Ufr/
PO4 has also been suggested from mechanistic studies with
Ufr and other divalent metal derivatives. (28)
FIGURE 3: Background corrected cyclic voltammograms of Uf at
pH 4.1 in order of increasing current magnitude (20, 50, 100, and
200 mV s-1). Inset: linear scan rate dependence of anodic and
cathodic current maxima.
E(H+) ) Eo + RTF ln(Ka(Ufr) + [H+]Ka(Ufo) + [H+]) + RTF ln(Ka(Ufo)Ka(Ufr))
(1)
FIGURE 4: Redox potentials of Uf (b) and its phosphate (9) and
arsenate (2) complexes as a function of pH. The solid lines were
calculated from eq 1 with pKa(Ufo) ) 5.2; pKa(Ufo/PO4) ) 4.4,
and pKa(Ufo/AsO4) ) 3.8.
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As mentioned previously, Ufr is inhibited by a variety of
tetraoxo anions such as phosphate and arsenate, and it has
been known for some time (23, 44) that phosphate binding
potentiates the aerobic oxidation of Ufr, which is normally
air stable. These observations suggested that the Uf redox
potential is shifted cathodically in the presence of phosphate.
The results of Wang et al. (34) and the work presented
herein confirm this. The corollary of this in electrochemical
terms is that the Uf redox potential in the presence of an
oxoanion inhibitor (XO4) will be cathodically shifted if
binding to the oxidized form is stronger than that to the
reduced form according to eq 2 (42), a variant on eq 1
involving complexation equilibria rather than protonation
equilibria.
In the presence of saturating concentrations of the anion (i.e.,
where both Ufo and Ufr have an oxoanion bound at the active
site), the second term of eq 2 vanishes and we arrive at eq
3, which gives the ratio of complex dissociation constants
from the difference (¢E) between the redox potentials of
the complexed and free enzymes.
It should be noted that the phosphate and arsenate complex
dissociation constants are pH dependent (23), and so too will
be ¢E. The relevant literature data and experimental results
are assembled in Table 1. Using eq 1 and the determined
pKa values for Ufo, Ufo(PO4), and Ufo(AsO4), we calculated
¢E values to correspond with pH values at which the Ufr
complex dissociation constants with phosphate and arsenate
have been reported and then used eq 3 to calculate Kd(Ufo-
(XO4)) at the corresponding pH value. It can be seen that
¢E increases as the pH is raised, but interestingly, the
Kd(Ufo(XO4)) values are essentially pH independent. Al-
though no dissociation constant data for arsenate binding to
Ufr at low pH are available, our results indicate that below
pH 4.5 arsenate binds more tightly to Ufr than to Ufo (¢E >
0) in contrast to phosphate, which is more strongly bound
to Ufo at all pH values investigated. This feature has not
been noted previously and reflects a subtle but significant
difference between the two anions in their interactions with
the active site.
The results presented in Table 1 are now compared with
those of Wang et al. (34), who used mediated microcou-
lometry to determine ¢E values and hence dissociation
constants for Ufo (eq 3) with phosphate and arsenate at pH
5.0 and 6.0. The microcoulometry study reported ¢E values
(approximately -170 mV for phosphate and approximately
-90 mV for arsenate), about twice as large as those found
here from cyclic voltammetry. Although we were able to
study the complexation behavior over a much wider pH range
and also at several different pH values, our calculated binding
constants are 1 to 2 orders of magnitude weaker than those
determined by microcoulometry. In the absence of Kd(Ufo/
XO4) values determined by other methods, we cannot offer
an explanation for this variance. If the values of Wang et al.
represent the true equilibrium constants in solution, then there
may be a specific effect associated with immobilization of
the enzyme within a surfactant film that weakens oxoanion
binding in its oxidized form. Why this effect should lead to
smaller differential inhibitor binding, and not to an across-
the-board influence felt equally by Ufr and Ufo, is not clear,
and further speculation seems unwarranted until more
thermodynamic data become available on the binding of
oxoanions by Ufo.
CONCLUSIONS
For the first time, we have successfully investigated the
direct electrochemistry of a purple acid phosphatase. Indeed,
reports of the direct electrochemistry of any other dinuclear
iron containing protein have been sparse, with the soluble
methane monooxygenase being the sole example (45, 46).
The advantages of the direct electrochemical techniques
described herein over mediated potentiometric or microcou-
lometric titrations are many (35). Rapid data acquisition using
cyclic voltammetry is possible enabling the study of a wide
range of pH values to be undertaken with the same aliquot
of protein solution within a short time interval (60 min).
Second, the amount of protein used in this work for a full
pH profile (1 nmol), although large by comparison with
our previous electrochemical studies using DDAB surfactant
films, is much less than that needed for microcoulometry
(20 nmol for each pH determination). Also, voltammetri-
cally determined redox potentials are inherently more precise,
as they correspond with current maxima derived from several
thousand data (current-voltage) points, whereas potentio-
metrically and coulometrically determined redox potentials
are derived from Nernstian fits to a dozen or so experimental
points. Cyclic voltammetry also enables the study of time-
dependent coupled chemical reactions that may affect the
reversibility of a particular electron-transfer reaction. In this
study, we found no pH or oxoanion effect on the reversibility
of the Uf redox couple, with totally reversible responses
being observed in all cases. This work represents the first
voltammetric investigation of an interesting class of enzymes.
Opportunities now exist to probe the effect of other inhibitors
on the redox properties of these proteins, and hopefully this
work and future studies will lead to a greater understanding
of the role of these interesting metalloenzymes and their
mechanism.
Table 1: Electrochemical Data and Derived Anion Complex
Dissociation Constants
pH ¢E (mV) Kd(Ufr/XO4) (mM)a Kd(Ufo/XO4) (mM)b
phosphate 3.0 -20 0.8 0.4
4.0 -27 3.8 1.3
4.5 -37 6.2 1.5
4.9 -49 14 2.1
5.5 -62 22 2.0
6.0 -68 25 1.8
arsenate 4.9 -24 1.3 0.5
6.0 -48 2.0 0.3
a Data from ref 23. b From this work, calculated using eq 3.
E(XO4) ) Eo + RTF ln(Kd(Ufr/XO4) + [XO4]Kd(Ufo/XO4) + [XO4]) +
RT
F ln(Kd(Ufo/XO4)Kd(Ufr/XO4)) (2)
¢E ) E(Uf/XO4,sat) - Eo ) RTF ln(Kd(Ufo/XO4)Kd(Ufr/XO4) ) (3)
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